MicroRNAs in the Cholangiopathies: Pathogenesis, Diagnosis, and Treatment
AbstractThe cholangiopathies are a group of liver diseases resulting from different etiologies but with the cholangiocyte as the primary target. As a group, the cholangiopathies result in significant morbidity and mortality and represent one of the main indications for liver transplant in both children and adults. Contributing to this situation is the absence of a thorough understanding of their pathogenesis and a lack of adequate diagnostic and prognostic biomarkers. MicroRNAs are small non-coding RNAs that modify gene expression post-transcriptionally. They have been implicated in the pathogenesis of many diseases, including the cholangiopathies. Thus, in this review we provide an overview of the literature on miRNAs in the cholangiopathies and discuss future research directions. View Full-Text
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Pisarello, M.J.L.; Loarca, L.; Ivanics, T.; Morton, L.; LaRusso, N. MicroRNAs in the Cholangiopathies: Pathogenesis, Diagnosis, and Treatment. J. Clin. Med. 2015, 4, 1688-1712.
Pisarello MJL, Loarca L, Ivanics T, Morton L, LaRusso N. MicroRNAs in the Cholangiopathies: Pathogenesis, Diagnosis, and Treatment. Journal of Clinical Medicine. 2015; 4(9):1688-1712.Chicago/Turabian Style
Pisarello, Maria J.L.; Loarca, Lorena; Ivanics, Tommy; Morton, Leslie; LaRusso, Nicholas. 2015. "MicroRNAs in the Cholangiopathies: Pathogenesis, Diagnosis, and Treatment." J. Clin. Med. 4, no. 9: 1688-1712.